Skip to main content

news

 

Latham & Watkins and Mah-Kamariyah & Philip Koh have advised Malaysian palm oil company Johor Plantations Group on its 735-million-ringgit ($157 million) initial public offering, the country's biggest in more than two years.

Linklaters and Christopher & Lee Ong, Rajah & Tann’s Malaysia member firm, advised the joint global coordinators and joint bookrunners, namely RHB Investment Bank, AmInvestment Bank, CIMB, CLSA, and Affin Hwang Investment Bank.

According to Reuters, this is the biggest IPO in Malaysia since March 2022, when dairy producer Farm Fresh raised 1 billion ringgit. It added that of the 735 million ringgit raised by Johor Plantation Group, about 345.2 million ringgit would go to sole selling shareholder Kulim, a unit of Johor state government agency Johor Corp.

Malaysia has been the best-performing market in Southeast Asia for IPOs in the first half of this year, with a total of 21 companies raising around $450 million during that time.

The Latham team was led by Singapore partners Sharon Lau and Stacey Wong, with foreign legal consultant Mara Recto. Advice was also provided on ESG matters by London partner Paul Davies and Washington, D.C. partner Sarah Fortt, with London counsel Michael Green and associate James Bee.

The Linklaters team was led by Amit Singh, head of South and Southeast Asia capital markets, with support from counsel Joseph Wolpin.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Paul Hastings, Latham lead on $827 mln LG CNS Korea IPO

Paul Hastings has advised South Korean tech services firm and LG Group member company LG CNS on its 1.2-trillion-won ($827 million) global offering and listing on the Korea Exchange, with Latham & Watkins advising the bookrunners.

SAM, Khaitan act on WeWork India’s upcoming $460 mln IPO

by Nimitt Dixit |

Shardul Amarchand Mangaldas is advising WeWork India, the Indian franchisee of U.S. shared office space manager WeWork, on its upcoming initial public offering (IPO) valued at $460 million.

MoFo, Ropes, Mori Hamada guide Bain's $3.3 bln Mitsubishi Pharma buyout

by Nimitt Dixit |

Morrison Foerster, Mori, Hamada & Matsumoto, and Ropes & Gray have advised U.S. investment fund Bain Capital on its planned 510-billion-yen ($3.3 billion) acquisition of Mitsubishi Tanabe Pharma Corporation from Mitsubishi Chemical Group Corporation.